{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T20:24:21Z","timestamp":1791750261309,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ygyno.2008.10.010","type":"journal-article","created":{"date-parts":[[2008,12,21]],"date-time":"2008-12-21T05:50:55Z","timestamp":1229838655000},"page":"6-10","source":"Crossref","is-referenced-by-count":69,"title":["A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma"],"prefix":"10.1016","volume":"112","author":[{"given":"Dennis S.","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena J.","family":"Palayekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Eisenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.10.010_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2008.10.010_bib2","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2008.10.010_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1006\/gyno.1994.1346","article-title":"Epithelial ovarian carcinoma: principles of primary surgery","volume":"55","author":"Hoskins","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/gyno.1997.4839","article-title":"Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?","volume":"67","author":"Le","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1006\/gyno.2001.6328","article-title":"Identification of prognostic factors in advanced ovarian epithelial carcinoma","volume":"82","author":"Chi","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.2000.5749","article-title":"The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma","volume":"77","author":"Chi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC\u2013IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib11","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2008.10.010_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2006.11.025","article-title":"Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease","volume":"105","author":"Hou","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian cancer","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib16","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","article-title":"A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography","volume":"89","author":"Bristow","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.10.010_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/j.1600-0412.2001.080006583.x","article-title":"Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer","volume":"80","author":"Gemer","year":"2001","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ygyno.2008.10.010_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/gyno.2002.6719","article-title":"Can serum CA-125 levels predict the optimal cytoreduction in patients with advanced ovarian carcinoma?","volume":"86","author":"Saygili","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0029-7844(02)02057-4","article-title":"Preoperative CA-125 levels: an independent prognostic factor for epithelial ovarian cancer","volume":"100","author":"Cooper","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1525-1438.2003.13019.x","article-title":"CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer","volume":"13","author":"Memarzadeh","year":"2003","journal-title":"Int J of Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2008.10.010_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijgo.2003.10.006","article-title":"CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma","volume":"84","author":"Alcazar","year":"2004","journal-title":"Intl J Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2008.10.010_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000076236","article-title":"Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level","volume":"57","author":"Obediat","year":"2004","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ygyno.2008.10.010_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-002-0404-6","article-title":"A retrospective study of preoperative CA-125 levels in 82 patients with ovarian cancer","volume":"269","author":"Rossi","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2008.10.010_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1048-891x.2004.14065.x","article-title":"Preoperative predictors of suboptimal cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer","volume":"14","author":"Brockbank","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2008.10.010_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2004.07.045","article-title":"Factors associated with cytoreducibility among women with ovarian carcinoma","volume":"95","author":"Eltabbakh","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajog.2005.03.058","article-title":"Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer","volume":"193","author":"Everett","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejso.2005.05.009","article-title":"A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer","volume":"31","author":"Gemer","year":"2005","journal-title":"Eur J Sur Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1525-1438.2006.00573.x","article-title":"The utility of presurgical CA 125 to predict optimal tumor cytoreduction of epithelial ovarian cancer","volume":"16","author":"Barlow","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2008.10.010_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ygyno.2007.02.027","article-title":"A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer","volume":"105","author":"Gilani","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib30","doi-asserted-by":"crossref","unstructured":"Arits AH, Stoot JE, Botterweck AA, Roumen FJ, Voogd AC. Preoperative serum Ca-125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Int J Gynecol Cancer 2007 [epub ahead of print].","DOI":"10.1111\/j.1525-1438.2007.01064.x"},{"key":"10.1016\/j.ygyno.2008.10.010_bib31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2006.01.005","article-title":"Predicting \u201cunresectable\u201d ovarian cancer: taking aim at a moving target","volume":"100","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib32","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Computed tomography predictors of primary suboptimal cytoreduction in patients with advanced ovarian cancer: a multi-institutional reciprocal validation study","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.10.010_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2007.11.004","article-title":"Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer","volume":"108","author":"Salani","year":"2008","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808008858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T10:17:09Z","timestamp":1558001829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808008858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0090825808008858"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.10.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}